100% Quality Guarantee
PhD-Level Technical Support
Key Features

Rat Receptor tyrosine-protein kinase erbB-2 (Erbb2) ELISA Kit (RTEB1244)

SKU RTEB1244
Product Type ELISA Kit
Size 96 Assays
Uniprot P06494
Range 0.312-20 ng/mL
ELISA Type Sandwich
Synonyms Erbb2, p185neu, p185erbB2, Proto-oncogene c-ErbB-2, Epidermal growth factor receptor-related protein, Proto-oncogene Neu,
Reactivity Rat
$923

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Rat Receptor tyrosine-protein kinase erbB-2 (Erbb2) ELISA Kit

The Rat Receptor Tyrosine Protein Kinase ERBB-2 (ERBB2) ELISA Kit is a powerful tool for accurate measurement of ERBB2 levels in rat samples including serum, plasma, and cell culture supernatants. With its superior sensitivity and specificity, this kit delivers reliable and consistent results, making it an invaluable resource for various research studies.ERBB2, also known as HER2, is a key protein involved in cell growth and proliferation, with implications in cancer development and progression.

Monitoring ERBB2 levels can provide crucial insights into cancer biology and aid in the development of targeted therapies for cancer treatment.By using the Rat Receptor Tyrosine Protein Kinase ERBB-2 (ERBB2) ELISA Kit, researchers can gain a deeper understanding of ERBB2-related pathways and mechanisms, advancing our knowledge of cancer biology and potentially leading to new therapeutic strategies for cancer management.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose